Glycerides of lauric acid supplementation in the chicken diet enhances the humoral and cellular immune response to infectious bronchitis virus.

Publication date: Aug 01, 2024

Controlling pathogenic infections while reducing antibiotic usage is an important challenge during poultry production. In addition to vaccination strategies, several solutions to enhance the immune response against pathogens are evaluated. In this study, we aim to determine the effects of the glycerides of lauric acid (GLA) supplementation in chickens’ diets on humoral and cellular immune response pathogenic infections, using an in vivo model of infectious bronchitis virus (IBV). One-day-old Ross 308 broilers were vaccinated with live attenuated IBV and fed diets supplemented with or without GLA at 3 kg/ton. The levels of early (day 7) specific anti-IBV in sera were significantly increased in broilers fed GLA, compared to the control groups (P

Concepts Keywords
3kg Animal Feed
Chicken Animals
Live Antibodies, Viral
Pathogenic Antibodies, Viral
Vaccinated Broilers
Cell mediated response
Chickens
Coronavirus Infections
Cytokines
Cytokines
Diet
Dietary Supplements
Glycerides
Glycerides
Humoral immune response
IBV
Immune response
Immunity, Cellular
Immunity, Humoral
Infectious bronchitis virus
lauric acid
Lauric acid glycerides
Lauric Acids
Lauric Acids
Poultry Diseases
Viral Vaccines
Viral Vaccines

Semantics

Type Source Name
drug DRUGBANK Lauric Acid
disease VO Infectious bronchitis virus
disease MESH infections
disease IDO production
disease VO vaccination
disease IDO immune response
drug DRUGBANK Gamolenic acid
disease VO vaccinated
disease IDO cell
disease MESH Coronavirus Infections
disease IDO humoral immune response
disease MESH Poultry Diseases

Original Article

(Visited 1 times, 1 visits today)